Enterprise Evidence Report · NR-REPORT-V2.0

Netherlands
Neuroscience Intelligence

Netherlands neuroscience evidence report: current clinical, research, institution and source-linked intelligence.

Evidence rank #10 of 50 · Data maturity A · Research score 45.5 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.

⚗
242Curated trials
↗
71Recruiting trials
▦
530Publications
⌂
168Institutions

Executive interpretation

Netherlands ranks #10 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.

Methodology status

Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.

Methodology →

Leading sponsors

Radboud University Medical Center183 recruiting
Merck Sharp & Dohme LLC127 recruiting
Hoffmann-La Roche102 recruiting
University Medical Center Groningen93 recruiting
Maastricht University Medical Center91 recruiting
UMC Utrecht73 recruiting
Erasmus Medical Center71 recruiting
Novartis Pharmaceuticals60 recruiting
Boehringer Ingelheim60 recruiting
Amsterdam UMC, location VUmc50 recruiting

Disease activity

Parkinsons44trials
Alzheimers42trials
Epilepsy27trials
Other Neurology18trials
Stroke10trials
Multiple Sclerosis10trials
Autism9trials
Depression9trials
Neuro Oncology9trials
Neuromuscular8trials

Research institutions

Haga HospitalOpenAlexlinked institution
Brain Innovation (Netherlands)OpenAlexlinked institution
De ViersprongOpenAlexlinked institution
Beatrix KinderziekenhuisOpenAlexlinked institution
Netherlands Haemophilia SocietyOpenAlexlinked institution
IsalaOpenAlexlinked institution
Hanze University of Applied SciencesOpenAlexlinked institution
Amphia ZiekenhuisOpenAlexlinked institution

Clinical evidence trail

NCT07798674TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic AtaxiasRECRUITING
NCT07786883Dialectic Behaviour Therapy (DBT) for People With Autism: A Multiple Baseline Single Case DesignRECRUITING
NCT07775872Prospective Natural History Study of POLG DiseaseRECRUITING
NCT07668856Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 TrialsRECRUITING
NCT07586150Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)NOT_YET_RECRUITING
NCT07434973Stratification and Treatment in Early Psychosis Study - PROMOTENOT_YET_RECRUITING
NCT07373223Virtual Reality Schema Therapy Exercises With Parent and Child ModesRECRUITING
NCT07369076A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.RECRUITING
NCT07322887A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's DiseaseRECRUITING
NCT07259005Breathe Hard to Breathe Easy: Online Breathwork-Assisted Therapy for Social AnxietyRECRUITING
NCT07252739KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)RECRUITING
NCT07213700InRAD Observational StudyRECRUITING

Research evidence trail

PUBMEDThe relationship between product-based creativity and ADHD traits in children and the associations with later well-being.2027-02-01
PUBMEDCirculating microRNAs reflect hemorrhagic MRI markers in cerebral amyloid angiopathy.2027-01-01
PUBMEDDepressive symptom profiles and risk of cardiometabolic disease incidence.2027-01-01
PUBMEDMicrobiome signatures correlate with diet-mediated ADHD symptom reduction.2026-12-31
PUBMEDCerebral palsy: an update on its early detection.2026-12-20
PUBMEDA cell type enrichment analysis tool for brain DNA methylation data (CEAM).2026-12-01
PUBMEDPost-operative stun effect captured by local field potentials correlates to temporary symptom relief in an adolescent with dystonia: A case report.2026-12-01
PUBMEDThe microbiome and PTSD: a scoping review across preclinical and clinical studies.2026-12-01
PUBMEDHelping or controlling? A multi-method case study of a mother-daughter dyad and their interactions during trauma-focused therapy.2026-12-01
PUBMEDThe impact of social isolation on the development of alcohol use and alcohol addiction-related processes in animals: A systematic review.2026-12-01
PUBMEDModifiers of effectiveness and deterioration, and prognostic factors of adherence in internet-based interventions for treatment of perinatal depression: A systematic review and individual participant data meta-analysis.2026-12-01
PUBMEDRisk factors for revictimization during treatment in patients with co-occurring SUD and PTSD.2026-12-01

World Bank context

IT.NET.USER.ZSinternet_users_pct97.0% · 2024
NY.GDP.MKTP.CDgdp_current_usd$1,332.8B · 2025
NY.GDP.PCAP.CDgdp_per_capita_usd$73,684 · 2025
SE.PRM.ENRRschool_enrollment_primary_pct104.16 · 2023
SE.SEC.ENRRschool_enrollment_secondary_pct137.51 · 2023
SH.XPD.CHEX.GD.ZScurrent_health_expenditure_pct_gdp10.0% · 2024
SH.XPD.CHEX.PC.CDcurrent_health_expenditure_per_capita_usd$6,845 · 2024
SH.XPD.GHED.GD.ZSgovernment_health_expenditure_pct_gdp6.7% · 2023
SP.DYN.CBRT.INbirth_rate_crude9.20 · 2024
SP.POP.TOTLpopulation_total18,087,633 · 2025
SP.URB.TOTL.IN.ZSurban_population_pct95.9% · 2025

Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.

Sources and provenance

ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.

Limitations

Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.